IL27 anticorps (N-Term)
-
- Antigène Voir toutes IL27 Anticorps
- IL27 (Interleukin-27 Subunit alpha (IL27))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp IL27 est non-conjugé
-
Application
- Western Blotting (WB), Enzyme Immunoassay (EIA), Immunofluorescence (IF)
- Specificité
- This antibody reacts to IL-27.
- Purification
- Affinity chromatography purified via peptide column
- Immunogène
- Affinity chromatography purified via peptide column
- Isotype
- IgG
- Top Product
- Discover our top product IL27 Anticorps primaire
-
-
- Indications d'application
-
ELISA. Western Blot: 2 - 4 μg/mL. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Buffer
- PBS containing 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
-
- Antigène
- IL27 (Interleukin-27 Subunit alpha (IL27))
- Autre désignation
- Interleukin-27 / IL27A (IL27 Produits)
- Synonymes
- anticorps IL-27, anticorps IL-27A, anticorps IL27A, anticorps IL27p28, anticorps IL30, anticorps p28, anticorps EUROIMAGE1875335, anticorps IL25, anticorps IL27, anticorps IL27w, anticorps R33729_1, anticorps SF20, anticorps IL-27p28, anticorps Il30, anticorps interleukin 27, anticorps myeloid derived growth factor, anticorps IL27, anticorps MYDGF, anticorps Il27
- Sujet
- Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naive but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-γ, and T-bet.Synonyms: IL-27 subunit alpha, IL-30, IL27-A, IL30, Interleukin-30, p28
- ID gène
- 246778
- NCBI Accession
- NP_663634
- UniProt
- Q8NEV9
-